FDA Adverse Event Death Summary report: N

PK PAPYRUS US 3.0/15

MDR report key: 22044301 · Received May 19, 2025

Report

Report Number
1028232-2025-02437
Event Type
Death
Date Received
May 19, 2025
Date of Event
April 30, 2025
Report Date
June 18, 2025
Manufacturer
BIOTRONIK AG, BUELACH, SWITZERLAND
Product Code
NIV
UDI-DI
07640130447165
PMA / PMN Number
H170004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE AFFECTED PK PAPYRUS STENT SYSTEM WAS NOT RETURNED TO BIOTRONIK AND COULD THEREFORE NOT BE SUBJECTED TO A TECHNICAL INVESTIGATION. IMAGES OF THE CASE SUCH AS ANGIOGRAPHIES COULD ALSO NOT BE OBTAINED. THE PROVIDED CLINICAL INFORMATION (PK PAPYRUS DEVICE REGISTRATION FORM, CATHLAB REPORT) AND THE PRODUCTION DOCUMENTATION WERE REVIEWED TO ESTABLISH WHETHER A DEVICE DEFICIENCY CONTRIBUTED TO THE EVENT. REVIEW OF THE PRODUCTION DOCUMENTATION CONFIRMED THAT THE DEVICE WAS MANUFACTURED ACCORDING TO SPECIFICATIONS AND FULFILLED ALL THE REQUIREMENTS OF IN-PROCESS AND FINAL INSPECTION. BASED ON THE PROVIDED DOCUMENTATION AND THE CONDUCTED REVIEW, NO MANUFACTURING RELATED ROOT CAUSE COULD BE IDENTIFIED. THE TREATING PHYSICIAN RATED THE OUTCOME AS NO DEVICE- BUT PROCEDURE-RELATED COMPLICATION. IT SHOULD BE NOTED THAT THE IFU ADVISES THE USER TO SELECT THE STENT SIZE TO MATCH THE DIAMETER OF THE VESSEL TO ACHIEVE A FINAL STENT DIAMETER TO VESSEL RATIO OF 1:1. PK PAPYRUS IS INDICATED FOR THE TREATMENT OF ACUTE PERFORATIONS OF NATIVE CORONARY ARTERIES AND CORONARY BYPASS GRAFTS IN VESSELS 2.5 TO 5.0 MM IN DIAMETER. AS SUCH, THIS DEVICE IS TYPICALLY USED IN EMERGENT RESPONSE TO A LIFE-THREATENING ADVERSE PROCEDURAL EVENT UNRELATED TO USE OF THE PK PAPYRUS.

Description of Event or Problem · 0

PK PAPYRUS COVERED STENT SYSTEMS WERE SELECTED FOR TREATMENT OF A TYPE III CS/IV PERFORATION (15 MM LENGTH) OCCURRED DURING POST-DILATATION OF A DES. AFTER THE FIRST PK PAPYRUS (COMPLAINT DEVICE) WAS PLACED, THE PERFORATION WAS NOT COMPLETELY SEALED SO A SECOND PK PAPYRUS WAS DEPLOYED. A POSSIBLE EDGE DISSECTION AT THE EDGE OF THE SECOND STENT SUSPECTED (REPORTED SEPARATELY), SO AN ONYX FRONTIER WAS DEPLOYED. AFTERWARDS, AN IMPELLA WAS PLACED AND THE PATIENT LEFT CATH LAB TO ICU. PATIENT CONTINUED TO HAVE SEVERE HEMODYNAMIC COMPROMISE DESPITE INCREASING MECHANICAL SUPPORT. FAMILY ULTIMATELY DECIDED TO WITHDRAW CARE. ADDITIONAL PATIENT CODE E0504.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2142974 PK PAPYRUS US 3.0/15 COVERED CORONARY STENT NIV BIOTRONIK AG, BUELACH, SWITZERLAND 434888 12230093 07640130447165

Patients

Seq Age Sex Outcome Treatment
1 83 YR Female Death